122 related articles for article (PubMed ID: 1280447)
1. Treatment of subfoveal choroidal neovascular membranes with systemic interferon-alpha 2a.
Loughnan MS; Heriot WJ; O'Day J
Aust N Z J Ophthalmol; 1992 Aug; 20(3):173-5. PubMed ID: 1280447
[TBL] [Abstract][Full Text] [Related]
2. Interferon alpha-2a in the treatment of exudative senile macular degeneration.
Jaakkola A; Anttila PM; Immonen I
Acta Ophthalmol (Copenh); 1994 Oct; 72(5):545-9. PubMed ID: 7534027
[TBL] [Abstract][Full Text] [Related]
3. Interferon alfa-2a in the treatment of subfoveal choroidal neovascularization.
Thomas MA; Ibanez HE
Am J Ophthalmol; 1993 May; 115(5):563-8. PubMed ID: 7683842
[TBL] [Abstract][Full Text] [Related]
4. Interferon alpha-2a treatment of patients with subfoveal neovascular macular degeneration. A pilot investigation.
Engler CB; Sander B; Koefoed P; Larsen M; Vinding T; Lund-Andersen H
Acta Ophthalmol (Copenh); 1993 Feb; 71(1):27-31. PubMed ID: 7682747
[TBL] [Abstract][Full Text] [Related]
5. The treatment of choroidal neovascular membranes by alpha interferon. An efficacy and toxicity study.
Chan CK; Kempin SJ; Noble SK; Palmer GA
Ophthalmology; 1994 Feb; 101(2):289-300. PubMed ID: 7509472
[TBL] [Abstract][Full Text] [Related]
6. Treatment of choroidal neovascularisation in age-related macular degeneration with interferon alfa-2a and alfa-2b.
Gillies MC; Sarks JP; Beaumont PE; Hunyor AB; McKay D; Kearns M; McClusky PJ; Sarks SH
Br J Ophthalmol; 1993 Dec; 77(12):759-65. PubMed ID: 7509184
[TBL] [Abstract][Full Text] [Related]
7. Interferon alfa-2a is ineffective for patients with choroidal neovascularization secondary to age-related macular degeneration. Results of a prospective randomized placebo-controlled clinical trial. Pharmacological Therapy for Macular Degeneration Study Group.
Arch Ophthalmol; 1997 Jul; 115(7):865-72. PubMed ID: 9230826
[TBL] [Abstract][Full Text] [Related]
8. Interferon alpha-2a for subfoveal neovascularization in age-related macular degeneration.
Poliner LS; Tornambe PE; Michelson PE; Heitzmann JG
Ophthalmology; 1993 Sep; 100(9):1417-24. PubMed ID: 8371932
[TBL] [Abstract][Full Text] [Related]
9. Treatment of choroidal neovascularization in age-related macular degeneration with interferon alpha-2a: a short term, nonrandomized pilot study.
Thoelen A; Menozzi M; Huber C; Messmer E
Ger J Ophthalmol; 1995 May; 4(3):137-43. PubMed ID: 7545047
[TBL] [Abstract][Full Text] [Related]
10. Clinical experience with interferon alfa-2a for exudative age-related macular degeneration.
Kirkpatrick JN; Dick AD; Forrester JV
Br J Ophthalmol; 1993 Dec; 77(12):766-70. PubMed ID: 7509185
[TBL] [Abstract][Full Text] [Related]
11. Intravitreal interferon alpha-2b for the treatment of neovascular age-related macular degeneration: a pilot study.
Kertes PJ; Britton WA; Leonard BC
Can J Ophthalmol; 1997 Apr; 32(3):185-8. PubMed ID: 9131284
[No Abstract] [Full Text] [Related]
12. Long-term outcomes after the surgical removal of advanced subfoveal neovascular membranes in age-related macular degeneration.
Ormerod LD; Puklin JE; Frank RN
Ophthalmology; 1994 Jul; 101(7):1201-210. PubMed ID: 7518575
[TBL] [Abstract][Full Text] [Related]
13. Interferon for subfoveal choroidal neovascularisation.
Groeneveld E; Eliadis P
Aust N Z J Ophthalmol; 1993 May; 21(2):133-4. PubMed ID: 7687445
[No Abstract] [Full Text] [Related]
14. Interferon alfa-2a modifies the course of subfoveal and juxtafoveal choroidal neovascularisation.
Engler C; Sander B; Villumsen J; Lund-Andersen H
Br J Ophthalmol; 1994 Oct; 78(10):749-53. PubMed ID: 7528534
[TBL] [Abstract][Full Text] [Related]
15. Surgical removal of idiopathic, myopic and age-related subfoveal neovascularization.
Bottoni F; Airaghi P; Perego E; Ortolina S; Carlevaro G; De Molfetta V
Graefes Arch Clin Exp Ophthalmol; 1996 Aug; 234 Suppl 1():S42-50. PubMed ID: 8871149
[TBL] [Abstract][Full Text] [Related]
16. Systemic interferon-alpha 2a and subretinal neovascular membranes.
Constable I
Aust N Z J Ophthalmol; 1992 Aug; 20(3):155. PubMed ID: 1280446
[No Abstract] [Full Text] [Related]
17. Retinotomy and foveal translocation for surgical management of subfoveal choroidal neovascular membranes.
Ninomiya Y; Lewis JM; Hasegawa T; Tano Y
Am J Ophthalmol; 1996 Nov; 122(5):613-21. PubMed ID: 8909200
[TBL] [Abstract][Full Text] [Related]
18. Well-defined subfoveal choroidal neovascular membranes in age-related macular degeneration.
Lopez PF; Lambert HM; Grossniklaus HE; Sternberg P
Ophthalmology; 1993 Mar; 100(3):415-22. PubMed ID: 7681555
[TBL] [Abstract][Full Text] [Related]
19. Feeder vessel photocoagulation of subfoveal choroidal neovascularization secondary to age-related macular degeneration.
Shiraga F; Ojima Y; Matsuo T; Takasu I; Matsuo N
Ophthalmology; 1998 Apr; 105(4):662-9. PubMed ID: 9544641
[TBL] [Abstract][Full Text] [Related]
20. Risk factors for choroidal neovascularization in the second eye of patients with juxtafoveal or subfoveal choroidal neovascularization secondary to age-related macular degeneration. Macular Photocoagulation Study Group.
Arch Ophthalmol; 1997 Jun; 115(6):741-7. PubMed ID: 9194725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]